Table 2. Peripheral and aortic hemodynamic parameters of the study population according to glucose tolerance status.
All | NGT<155 | NGT≥155 | IGT | P | |
Variables | (n = 584) | (n = 278) | (n = 146) | (n = 160) | |
Heart rate, bts/min | 69±9 | 70±9 | 69±9 | 68±8 | 0.067 |
systolic BP, mmHg | 145±13 | 145±11 | 144±14 | 145±14 | 0.711 |
diastolic BP, mmHg | 91±7 | 91±7 | 92±7 | 91±8 | 0.357 |
mean BP, mmHg | 109±7 | 109±6 | 109±7 | 109±8 | 0.999 |
PP, mmHg | 54±14 | 54±13 | 53±14 | 54±15 | 0.751 |
c-systolicBP, mmHg | 133±11 | 131±10 | 134±12 | 134±10 | 0.003 |
c-diastolic BP, mmHg | 92±6 | 92±5 | 93±5 | 92±6 | 0.143 |
c-PP, mmHg | 40±11 | 38±10 | 42±13 | 42±10 | <0.0001 |
AP, mmHg | 11.4±6.5 | 9.8±5.7 | 12.5±7.1 | 13.1±6.5 | <0.0001 |
AI, % | 27.7±12.5 | 25.1±12.4 | 29.4±11.9 | 30.7±12.5 | <0.0001 |
PWV, m/s | 7.5±2.7 | 6.7±1.7 | 8.4±3.7 | 8.2±2.9 | <0.0001 |
χ2 test; NGT = normal glucose tolerance; IGT = impaired glucose tolerance; DM = diabetes mellitus; BMI = body mass index; ISI = insulin sensitivity index; MS = metabolic syndrome; hs-CRP = high sensitivity C reactive protein; BP = blood pressure; PP = pulse pressure; c = central; PWV = pulse wave velocity; AP = augmentation pressure; AI = augmentation index.